Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/LY-272,015> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- LY-272,015 abstract "LY-272,015 is a beta-carboline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models, and is also used in research into the other functions of the 5-HT2B receptor.".
- LY-272,015 casNumber "172895-15-7".
- LY-272,015 iupacName "1-(3,4-dimethoxybenzyl)-6-methyl-2,3,4,9-tetrahydro-1H-β-carboline".
- LY-272,015 pubchem "9929424".
- LY-272,015 thumbnail LY-272,015_structure.png?width=300.
- LY-272,015 wikiPageID "20567520".
- LY-272,015 wikiPageLength "2414".
- LY-272,015 wikiPageOutDegree "11".
- LY-272,015 wikiPageRevisionID "545511551".
- LY-272,015 wikiPageWikiLink 5-HT2B_receptor.
- LY-272,015 wikiPageWikiLink Beta-Carboline.
- LY-272,015 wikiPageWikiLink Category:5-HT2B_antagonists.
- LY-272,015 wikiPageWikiLink Category:Beta-Carbolines.
- LY-272,015 wikiPageWikiLink Category:Eli_Lilly_and_Company.
- LY-272,015 wikiPageWikiLink Category:Phenol_ethers.
- LY-272,015 wikiPageWikiLink Eli_Lilly_and_Company.
- LY-272,015 wikiPageWikiLink Hypertension.
- LY-272,015 wikiPageWikiLink Receptor_(biochemistry).
- LY-272,015 wikiPageWikiLink Receptor_antagonist.
- LY-272,015 wikiPageWikiLink Serotonin.
- LY-272,015 wikiPageWikiLinkText "LY-272,015".
- LY-272,015 c "21".
- LY-272,015 casNumber "172895".
- LY-272,015 h "24".
- LY-272,015 iupacName "1".
- LY-272,015 molecularWeight "336.426".
- LY-272,015 n "2".
- LY-272,015 o "2".
- LY-272,015 pubchem "9929424".
- LY-272,015 smiles "c4cccc3c4nc2c3CCNC2Ccccc1OC".
- LY-272,015 synonyms "(LY-272,015; 1-[methy]-2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indole)".
- LY-272,015 verifiedrevid "442357145".
- LY-272,015 width "220".
- LY-272,015 wikiPageUsesTemplate Template:Drugbankcite.
- LY-272,015 wikiPageUsesTemplate Template:Drugbox.
- LY-272,015 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- LY-272,015 wikiPageUsesTemplate Template:Reflist.
- LY-272,015 wikiPageUsesTemplate Template:Serotonergics.
- LY-272,015 subject Category:5-HT2B_antagonists.
- LY-272,015 subject Category:Beta-Carbolines.
- LY-272,015 subject Category:Eli_Lilly_and_Company.
- LY-272,015 subject Category:Phenol_ethers.
- LY-272,015 hypernym Drug.
- LY-272,015 type ChemicalSubstance.
- LY-272,015 type Company.
- LY-272,015 type Drug.
- LY-272,015 type Antagonist.
- LY-272,015 type Chemical.
- LY-272,015 type Company.
- LY-272,015 type Drug.
- LY-272,015 type Ether.
- LY-272,015 type Heterocycle.
- LY-272,015 type ChemicalObject.
- LY-272,015 type Thing.
- LY-272,015 type Q8386.
- LY-272,015 comment "LY-272,015 is a beta-carboline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models, and is also used in research into the other functions of the 5-HT2B receptor.".
- LY-272,015 label "LY-272,015".
- LY-272,015 sameAs Q6460411.
- LY-272,015 sameAs m.0520329.
- LY-272,015 sameAs LY-272,015.
- LY-272,015 sameAs LY-272,015.
- LY-272,015 sameAs Q6460411.
- LY-272,015 wasDerivedFrom LY-272,015?oldid=545511551.
- LY-272,015 depiction LY-272,015_structure.png.
- LY-272,015 isPrimaryTopicOf LY-272,015.